{"i": ["placebo or oral riociguat", "PEA", "pulmonary angiogram supplemented by a ventilation - perfusion ( VQ ) scan", "endothelin receptor antagonist , prostacyclin analogue , phosphodiesterase type 5 inhibitor or NO donor", "Riociguat Placebo", "placebo - controlled", "placebo", "PEA Riociguat", "CT pulmonary angiogram ( minimum 64 - slice spiral CT with contrast medium ) supplemented by a VQ scan .", "Riociguat", "Placebo", "Pulmonary endarterectomy ( PEA )", "riociguat", "placebo ."], "o": ["AEs", "cardiac output", "Haemodynamic parameters", "PVR , mPAP and MAP .", "mean arterial pressure ( MAP ), mPAP , PVR , systemic vascular resistance ( SVR ), pulmonary diastolic pressure gradient ( DPG ) and cardiac index .", "NT - proBNP and WHO functional class", "heart rate", "haemodynamic parameters , including RAP , PAWP , cardiac output and mixed venous oxygen saturation ( SvO2 ).", "Inoperable Persistent / recurrent PH", "haemodynamic parameters and NT - proBNP", "PVR , cardiac output , cardiac index , mPAP and DPG", "exercise capacity", "Dizziness", "pulmonary vascular resistance ( PVR )", "mean \u00b1 SD SBP", "PVR and cardiac index", "CTEPH and persistent / recurrent PH", "dPAP", "Diastolic pulmonary artery pressure", "Headache", "DPG", "Mean \u00b1 SD arterial oxygen saturation", "PVR , NT - proBNP and WHO functional class and time to clinical worsening .", "haemodynamic data ( at least mean right atrial pressure ( RAP ), mPAP , PVR , cardiac output and pulmonary artery wedge pressure ( PAWP ))", "cardiac index", "change from BL in haemodynamic parameters", "haemodynamic variables ( PVR and cardiac index ).", "PVR , mPAP , RAP and cardiac index", "haemodynamic parameters", "haemodynamic", "CTEPH , chronic thromboembolic pulmonary hypertension ; dPAP , diastolic pulmonary artery pressure ; DPG , diastolic pressure gradient ; LS , least - squares ; MAP , mean arterial pressure ; mPAP , mean pulmonary artery pressure ; PAWP , pulmonary artery wedge pressure ; PEA , pulmonary endarterectomy ; PH , pulmonary hypertension ; PVR , pulmonary vascular resistance ; RAP , right atrial pressure ; SvO 2 , mixed venous oxygen saturation ; SVR , systemic vascular resistance .", "PVR , SVR , mPAP , cardiac output , cardiac index , SvO2 and MAP", "PVR , mPAP , cardiac index and SvO2", "Mean pulmonary artery pressure", "Mean \u00b1 SD SBP", "6MWD and PVR", "SVR", "PVR , mPAP , SvO2 and cardiac index", "systolic blood pressure ( SBP )", "RAP and PAWP", "6 min walk distance ( 6MWD )", "6MWD", "Cardiac index", "mPAP", "haemodynamic impairments", "haemodynamics", "SvO2", "PVR , SVR and cardiac index", "6MWD versus cardiac index", "haemodynamic parameters , 6MWD and NT - proBNP", "Dyspepsia", "haemodynamic improvements", "NT - proBNP", "haemodynamic variables", "Adverse events ( AEs )", "6MWD and change in PVR and cardiac index", "6MWD .", "MAP", "6MWD , 6 min walk distance ; BMI , body mass index ; CTEPH , chronic thromboembolic pulmonary hypertension ; PEA , pulmonary endarterectomy ; PH , pulmonary hypertension ; WHO FC", "PVR and mPAP", "PVR and higher 6MWD", "AE of catheter - site haemorrhage", "6 min walk distance", "pulmonary vascular resistance ( PVR ), N - terminal prohormone of brain natriuretic peptide ( NT - proBNP ) levels and WHO functional class", "PVR", "mean \u00b1 SD heart rate"]}